On October 29, the 76th China International Medical Equipment Fair (CMEF) was held at Shenzhen Convention & Exhibition Center. On the largest medical equipment fair in the Asia-Pacific region, as the globally leading provider of gene sequencing system solutions for precision medicine, HYK has attended the event with its national key new product and nationally initiative clinical high-throughput gene sequencer--HYK-PSTAR-IIA gene sequencing system. It exhibited its achievements accumulated from eight years of innovation based on a theme of "Building a Leading Brand of Gene Sequencer in China".

In December 2014, the HYK-PSTAR-IIA gene sequencer independently developed and produced by HYK Gene won the registration certificate for medical devices from CFDA, which had filled the gap of China in clinical high-throughput gene sequencer, truly realize "made-in-China" gene sequencer for precision medicine and thoroughly overturned the long monopoly of the market of new generation gene sequencing by American companies. At present, the HYK-PSTAR-IIA gene sequencing system has been applied in fields such as early screening of critical diseases, guiding individualized precise medication, early screening of genetic diseases and metabolism, which fully covers the field of precision medicine. It has not only laid down a solid foundation for the extensive application of gene sequencing technology in the field of clinical precision medicine, but also effectively promoted the development of clinical precision medicine.

Daring to dream, realize the dream and pioneer, HYK has focused on client's demands and product quality for eight years and has won unanimous trust and praise from the clients. The gene sequencing industry is faced with challenges and opportunities. HYK is always shouldering a great mission to develop gene technology and benefit genetic health of Chinese people. It will move on steadily to continuously promote the stable development of precision medicine industry in China.